Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 726 items.
The Loss on Drying is out of specification in the affected lot.
RecallHealth product recall | 2023-03-21
In 2013, ISTODAX (romidepsin) was authorized under a Notice of Compliance with conditions (NOC/c) for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) who are not eligible for transplant and have received at least one…
AlertHealth professional risk communication | 2023-03-20
Canada is experiencing a shortage of nitroglycerin 0.4 MG/ACT sprays due to supply issues with the raw materials used to make the sprays as well as an increase in demand.
Nitroglycerin sublingual spray is applied under the tongue and is used to treat…
AlertPublic advisory | 2023-03-17
Vials may be cracked in affected lots.
RecallHealth product recall | 2023-03-03
Potential low Anti-Factor Ila potency out of specification.
RecallHealth product recall | 2023-03-01
Bacteria content is below specification in the affected lot.
RecallHealth product recall | 2023-03-01
Bacteria content is below specification in the affected lot.
RecallHealth product recall | 2023-03-01
Affected lots are incorrectly labelled for use in the pediatric subpopulation.
RecallHealth product recall | 2023-02-24
The dissolution is out of specification in the affected lot.
RecallHealth product recall | 2023-02-17
Currently available data from the NOVA study, based on a data cut-off date of October 1, 2020, shows that the median OS may be lower with ZEJULA compared to placebo for patients in the overall non-gBRCAmut cohort and the non-gBRCAmut / Homologous…
AlertHealth professional risk communication | 2023-02-16
Affected lot being voluntarily recalled due to reported adverse reactions possibly to niacin (reddening skin flush, heat sensation).
RecallHealth product recall | 2023-02-14
The affected lot may contain the presence of foreign matter.
RecallHealth product recall | 2023-02-14
Presence of foreign matter in affected lot.
RecallHealth product recall | 2023-02-13
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.
RecallHealth product recall | 2023-02-07
Affected lots may contain the presence of Cronobacter contamination.
RecallHealth product recall | 2023-02-02